These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25549587)

  • 1. Infectious diseases: Two-hit antibody tackles bacteria.
    Kingwell K
    Nat Rev Drug Discov; 2015 Jan; 14(1):15. PubMed ID: 25549587
    [No Abstract]   [Full Text] [Related]  

  • 2. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa.
    DiGiandomenico A; Keller AE; Gao C; Rainey GJ; Warrener P; Camara MM; Bonnell J; Fleming R; Bezabeh B; Dimasi N; Sellman BR; Hilliard J; Guenther CM; Datta V; Zhao W; Gao C; Yu XQ; Suzich JA; Stover CK
    Sci Transl Med; 2014 Nov; 6(262):262ra155. PubMed ID: 25391481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model.
    Patel A; DiGiandomenico A; Keller AE; Smith TRF; Park DH; Ramos S; Schultheis K; Elliott STC; Mendoza J; Broderick KE; Wise MC; Yan J; Jiang J; Flingai S; Khan AS; Muthumani K; Humeau L; Cheng LI; Wachter-Rosati L; Stover CK; Sardesai NY; Weiner DB
    Nat Commun; 2017 Sep; 8(1):637. PubMed ID: 28935938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients.
    Meng YG; Wong T; Saravolatz LD; Pennington JE
    J Infect Dis; 1993 Mar; 167(3):784-5. PubMed ID: 8440953
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F.
    Hancock RE; Mutharia LM; Mouat EC
    Eur J Clin Microbiol; 1985 Apr; 4(2):224-7. PubMed ID: 2408887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat.
    Landsperger WJ; Kelly-Wintenberg KD; Montie TC; Knight LS; Hansen MB; Huntenburg CC; Schneidkraut MJ
    Infect Immun; 1994 Nov; 62(11):4825-30. PubMed ID: 7927761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic human monoclonal antibodies directed to Pseudomonas aeruginosa].
    Noguchi H
    Nihon Rinsho; 1991 Oct; 49(10):2446-51. PubMed ID: 1749102
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients.
    Saravolatz LD; Markowitz N; Collins MS; Bogdanoff D; Pennington JE
    J Infect Dis; 1991 Oct; 164(4):803-6. PubMed ID: 1910070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A human monoclonal antibody cocktail for experimental mouse infection with clinically isolated strains of Pseudomonas aeruginosa].
    Miura S; Ishibashi Y; Arai T
    Kansenshogaku Zasshi; 1993 Dec; 67(12):1167-71. PubMed ID: 8294765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies.
    Lindorfer MA; Nardin A; Foley PL; Solga MD; Bankovich AJ; Martin EN; Henderson AL; Price CW; Gyimesi E; Wozencraft CP; Goldberg JB; Sutherland WM; Taylor RP
    J Immunol; 2001 Aug; 167(4):2240-9. PubMed ID: 11490011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
    Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
    J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats].
    Ren PX
    Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914
    [No Abstract]   [Full Text] [Related]  

  • 18. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
    Lang AB; Fürer E; Cryz SJ
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):9-13. PubMed ID: 8364527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.